Innovate UK

ProtectBox operates a cybersecurity comparison marketplace aimed at making cybersecurity solutions accessible to small and medium-sized businesses. The platform allows users to input their specific cybersecurity needs, which are then processed through an algorithm that generates a tailored set of security products and technologies. This customized approach not only enhances the security posture of businesses but also provides them with a competitive edge in their respective markets. By simplifying the selection process for cybersecurity solutions, ProtectBox addresses the challenges faced by small businesses in navigating complex protection advice, ultimately helping them safeguard their online activities more effectively.

ProtectBox operates a cybersecurity comparison marketplace aimed at making cybersecurity solutions accessible to small and medium-sized businesses. The platform allows users to input their specific cybersecurity needs, which are then processed through an algorithm that generates a tailored set of security products and technologies. This customized approach not only enhances the security posture of businesses but also provides them with a competitive edge in their respective markets. By simplifying the selection process for cybersecurity solutions, ProtectBox addresses the challenges faced by small businesses in navigating complex protection advice, ultimately helping them safeguard their online activities more effectively.

Almac Group is a prominent contract development and manufacturing organization based in Craigavon, United Kingdom, specializing in a comprehensive array of services for the pharmaceutical and biotech sectors. With over 40 years of organic growth, the company employs more than 4,500 skilled professionals and operates facilities in the UK, Ireland, the United States, and Asia. Almac Group's offerings encompass research and development, biomarker discovery and development, active pharmaceutical ingredient (API) manufacture, formulation development, clinical trial supply, and companion diagnostic development. The group also includes Almac Diagnostics, which focuses on biomarker discovery and validation, providing services such as bioinformatics solutions and genomic analyses. Additionally, Almac Discovery is dedicated to oncology, concentrating on innovative cancer treatment approaches during the discovery and preclinical stages. Through continuous investment in state-of-the-art technology and services, Almac Group supports clients throughout the entire biopharmaceutical product lifecycle, from preclinical development to commercialization.